Center-Authored Papers

Filters: Author is Miller, A Dusty  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Halbert CL, Miller AD.  2004.  AAV-mediated gene transfer to mouse lungs.. Methods in molecular biology (Clifton, N.J.). 246:201-12. Abstract
Vigdorovich V, Miller AD, Strong RK.  2007.  Ability of hyaluronidase 2 to degrade extracellular hyaluronan is not required for its function as a receptor for jaagsiekte sheep retrovirus.. Journal of virology. 81(7):3124-9. Abstract
Weintraub H, Tapscott SJ, Davis RL, Thayer MJ, Adam MA, Lassar AB, Miller AD.  1989.  Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD.. Proceedings of the National Academy of Sciences of the United States of America. 86(14):5434-8. Abstract
Metzger MJ, Miller AD.  2010.  Acutely transforming retrovirus expressing Nras generated from HT-1080 fibrosarcoma cells infected with the human retrovirus XMRV.. Journal of virology. 84(15):7908-10. Abstract
Halbert CL, Allen JM, Miller AD.  2001.  Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors.. Journal of virology. 75(14):6615-24. Abstract
Seiler MP, Miller AD, Zabner J, Halbert CL.  2006.  Adeno-associated virus types 5 and 6 use distinct receptors for cell entry.. Human gene therapy. 17(1):10-9. Abstract
Russell DW, Miller AD, Alexander IE.  1994.  Adeno-associated virus vectors preferentially transduce cells in S phase.. Proceedings of the National Academy of Sciences of the United States of America. 91(19):8915-9. Abstract
Halbert CL, Alexander IE, Wolgamot GM, Miller AD.  1995.  Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells.. Journal of virology. 69(3):1473-9. Abstract
Doty RT, Sabo KM, Chen J, Miller AD, Abkowitz JL.  2010.  An all-feline retroviral packaging system for transduction of human cells.. Human gene therapy. 21(8):1019-27. Abstract
Duh F-M, Dirks C, Lerman MI, Miller AD.  2005.  Amino acid residues that are important for Hyal2 function as a receptor for jaagsiekte sheep retrovirus.. Retrovirology. 2:59. Abstract
Sancho S, Mongini T, Tanji K, Tapscott SJ, Walker WF, Weintraub H, Miller AD, Miranda AF.  1993.  Analysis of dystrophin expression after activation of myogenesis in amniocytes, chorionic-villus cells, and fibroblasts. A new method for diagnosing Duchenne's muscular dystrophy.. The New England journal of medicine. 329(13):915-20. Abstract
Miller AD, Metzger MJ.  2011.  APOBEC3-mediated hypermutation of retroviral vectors produced from some retrovirus packaging cell lines.. Gene therapy. 18(5):528-30. Abstract
B
Miller AG.  1982.  Benzo(a)pyrene metabolism: induction in variant cells. Pharmacology. Ph.D.:330.
Miller AG, Israel D, Whitlock JP.  1983.  Biochemical and genetic analysis of variant mouse hepatoma cells defective in the induction of benzo(a)pyrene-metabolizing enzyme activity.. The Journal of biological chemistry. 258(6):3523-7. Abstract
Jones PB, Miller AG, Israel DI, Galeazzi DR, Whitlock JP.  1984.  Biochemical and genetic analysis of variant mouse hepatoma cells which overtranscribe the cytochrome P1-450 gene in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin.. The Journal of biological chemistry. 259(20):12357-63. Abstract
C
Miller AD, Curran T, Verma IM.  1984.  c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene.. Cell. 36(1):51-60. Abstract
Rai SK, Duh FM, Vigdorovich V, Danilkovitch-Miagkova A, Lerman MI, Miller AD.  2001.  Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation.. Proceedings of the National Academy of Sciences of the United States of America. 98(8):4443-8. Abstract
Stead RB, Kwok WW, Storb R, Miller AD.  1988.  Canine model for gene therapy: inefficient gene expression in dogs reconstituted with autologous marrow infected with retroviral vectors.. Blood. 71(3):742-7. Abstract
Halbert CL, Metzger MJ, Lam S-L, Miller AD.  2011.  Capsid-expressing DNA in AAV vectors and its elimination by use of an oversize capsid gene for vector production.. Gene therapy. 18(4):411-7. Abstract
Kavanaugh MP, Miller DG, Zhang W, Law W, Kozak SL, Kabat D, Miller AD.  1994.  Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters.. Proceedings of the National Academy of Sciences of the United States of America. 91(15):7071-5. Abstract
Miller AD.  1996.  Cell-surface receptors for retroviruses and implications for gene transfer.. Proceedings of the National Academy of Sciences of the United States of America. 93(21):11407-13. Abstract
Miller DG, Edwards RH, Miller AD.  1994.  Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus.. Proceedings of the National Academy of Sciences of the United States of America. 91(1):78-82. Abstract
Nitta Y, Kawamoto S, Halbert C, Iwata A, Miller AD, Miyazaki J-ichi, Allen MD.  2005.  A CMV-actin-globin hybrid promoter improves adeno-associated viral vector gene expression in the arterial wall in vivo.. The journal of gene medicine. 7(10):1348-55. Abstract
Miller AD, Garcia JV, von Suhr N, Lynch CM, Wilson C, Eiden MV.  1991.  Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus.. Journal of virology. 65(5):2220-4. Abstract
Rixon MW, Miller AD, Gelinas RE.  1987.  Construction of vectors to study expression of wild type and non deletion HPFH gamma globin genes.. Progress in clinical and biological research. 251:391-400.